Month: September 2024

CALGARY, Alberta, Sept. 18, 2024 (GLOBE NEWSWIRE) — MPIC Fund I LP (“MPIC“) announces that it has filed an early warning report (the “Early Warning Report“) under National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues in connection with the closing of the previously announced reverse takeover (the “Transaction” or the “RTO“) whereby MPIC acquired shares of Premier Diversified Holdings Inc. (the “Company” or “PDH“). In connection with the RTO (i) AJA Health and Wellness Ltd. (“AJA“) amalgamated with a wholly-owned subsidiary of the Company, 2564858 Alberta Inc., pursuant to the terms of an amalgamation agreement dated June 3, 2024, resulting in an amalgamated Alberta corporation, which is a wholly-owned...

At the close of business on 18 September 2024, Morten Opstad, chair of the board of IDEX Biometrics, held the following voting rights in IDEX, for the extraordinary general meeting on 23 September 2024. Total 41,982,551 shares or 12.4% of the share capital and vote, including shares held by Mr. Opstad and close relations. Some of the proxies may include voting instructions. Contact personMarianne Bøe, Head of Investor RelationsE-mail: marianne.boe@idexbiometrics.comTel: +47 9180 0186 About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity.  Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated...

Greenville, South Carolina, Sept. 18, 2024 (GLOBE NEWSWIRE) — ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) is pleased to report that it has implemented an integration that allows telehealth doctors and other practitioners to order diagnostic tests through physical locations connected by ARCpoint’s MyARCpointLabs technology platform. This integration is an enhancement to the Application Programming Interface (“API”) developed by MD Care Group, LLC,(“MD Care Group”) which is connected to ARCpoint’s MyARCpointLabs (“MAPL”) as originally reported November 21, 2023. ARCpoint CEO John Constantine commented “According to the US Centers for Disease Control and Prevention, 70% of today’s medical decisions depend on laboratory test results, (1) which can be an issue for telehealth providers, as telehealth practitioners often do...

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Sept. 18, 2024 (GLOBE NEWSWIRE) — Atrium Mortgage Investment Corporation (TSX: AI, AI.DB.D, AI.DB.E, AI.DB.F, AI.DB.G) (“Atrium”) announced today that it has entered into an agreement with a syndicate of underwriters bookrun by TD Securities Inc. and RBC Capital Markets, pursuant to which the underwriters will purchase 2,185,000 common shares (the “Shares”) of Atrium at a price of $11.45 per Share (the “Issue Price”) for gross proceeds of $25,018,250 (the “Offering”). Atrium has also granted to the underwriters an over-allotment option to purchase up to an additional 327,750 Shares at the Issue Price, exercisable in whole or in part at any time for a period of up to 30 days following closing of the Offering, to...

TORONTO, Sept. 18, 2024 (GLOBE NEWSWIRE) — North American Financial 15 Split Corp. (the “Company”) is pleased to announce that the minimum annual dividend rate for the Preferred Shares will increase to 7.00% from 5.5% for the new five year term effective December 1, 2024. The payment rate that may be reset annually, subject to the five year minimum, will be set at 8.75% (previously 9.50%) per annum effective December 1, 2024 based on the $10.00 repayment value. The Preferred shareholders have received a total of $11.38 per share in distributions since inception. The dividend policy for the Class A Shares will remain at the current targeted rate of $0.11335 per month, or $1.36 per annum. As previously announced on March 12, 2024 the Company will extend the termination date of the Company a further five year period from December...